Perioperative morphine and cancer recurrence

Morphine and Metastasis

Volumn , Issue , 2013, Pages 123-142

  Shilling, Ashley M ^a   Tiouririne, Mohamed ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

Author keywords

Analgesia; Anesthesia; Cancer; Metastasis; Morphine; Opioids; Pain management; Surgery

Indexed keywords

EID: 84956536935     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-94-007-5678-6_9     Document Type: Chapter

References (104)

1. Afsharimani B, Cabot PJ, Parat MO (2011) Morphine use in cancer surgery. Front Pharmacol 2:46
2. Amato A, Pescatori M (2006) Perioperative blood transfusions for the recurrence of colorectal cancer. Cochrane Database Syst Rev 1:CD005033. doi:10.1007/BF02235262
3. Anderson SK (2005) Biology of natural killer cells: what is the relationship between natural killer cells and cancer? Will an increased number and/or function of natural killer cells result in lower cancer incidence? J Nutr 135(12):2910S
4. Azuma Y, Shinohara M et al (2000) Comparison of inhibitory effects of local anesthetics on immune functions of neutrophils. Int J Immunopharmacol 22(10):789-796
5. Bar-Yosef S, Melamed R, Page GG et al (2001) Attenuation of the tumor-promoting effect of surgery by spinal blockade in rats. Anesthesiology 94:1066-1073
6. Beilin B, Martin FC, Shavit Y et al (1989) Suppression of natural killer cell activity by high-dose narcotic anesthesia in rats. Brain Behav Immun 3:129-137
7. Beilin B, Shavit Y, Hart J et al (1996) Effects of anesthesia based on large versus small doses of fentanyl on natural killer cell cytotoxicity in the perioperative period. Anesth Analg 82:492-497
8. Ben-Eliyahu S (2003) The promotion of tumor metastasis by surgery and stress: immunological basis and implications for psychoneuroimmunology. Brain Behav Immun 17(Suppl 1):S27-S36
9. Ben-Eliyahu S, Shakhar G, Rosenne E et al (1999) Hypothermia in barbiturate-anesthetized rats suppresses natural killer cell activity and compromises resistance to tumor metastasis: a role for adrenergic mechanisms. Anesthesiology 91:732-740
10. Benish M, Bartal I, Goldfarb Y et al (2008) Perioperative use of beta-blockers and COX-2 inhibitors may improve immune competence and reduce the risk of tumor metastasis. Ann Surg Oncol 15:2042-2052
11. Biki B, Mascha E, Moriarty DC et al (2008) Anesthetic technique for radical prostatectomy surgery affects cancer recurrence: a retrospective analysis. Anesthesiology 109:180-187
12. Bone RC (1996) Immunologic dissonance: a continuing evolution in our understanding of the systemic inflammatory response syndrome (SIRS) and the multiple organ dysfunction syndrome (MODS). Ann Intern Med 125:680-687
13. Bornemann-Cimenti H, Lederer AJ, Wejbora M et al (2012) Preoperative pregabalin administration significantly reduces postoperative opioid consumption and mechanical hyperalgesia after transperitoneal nephrectomy. Br J Anaesth 108:845-849
14. Brittenden J, Heys SD, Ross J, Eremin O et al (1996) Natural killer cells and cancer. Cancer 77:1226-1243
15. Bruzzone A, Pinero CP, Castillo LF et al (2008) Alpha2-adrenoceptor action on cell proliferation and mammary tumour growth in mice. Br J Pharmacol 155:494-504
16. Cadet P, Mantione KJ, Stefano GB (2003) Molecular identification and functional expression of mu 3, a novel alternatively spliced variant of the human mu opiate receptor gene. J Immunol 170:5118-5123
17. Cassuto J, Sinclair R, Bondorevic M et al (2006) Anti-inflammatory properties of local anesthetics and their present and potential clinical implications. Acta Anaesthesiol Scand 50(3):265-282
18. Chambrier C, Chassard D, Bienvenu J et al (1996) Cytokine and hormonal changes after cholecystectomy: effect of ibuprofen pretreatment. Ann Surg 224:178-182
19. Christopherson R, Beattie C, Frank SM et al (1993) Perioperative morbidity in patients randomized to epidural or general anesthesia for lower extremity vascular surgery. Perioperative Ischemia Randomized Anesthesia Trial Study Group. Anesthesiology 79:422-434
20. Christopherson R, James KE, Tableman M et al (2008) Long-term survival after colon cancer surgery: a variation associated with choice of anesthesia. Anesth Analg 107:325-332
21. Coderre TJ, Katz J, Vaccarino AL, Melzack R et al (1993) Contribution of central neuroplasticity to pathological pain: review of clinical and experimental evidence. Pain 52:259-285
22. Delogu G, Moretti S, Antonucci A et al (2004) Apoptogenic effect of fentanyl on freshly isolated peripheral blood lymphocytes. J Trauma 57:75-81
23. Demicheli R, Miceli R, Moliterni A et al (2005) Breast cancer recurrence dynamics following adjuvant CMF is consistent with tumor dormancy and mastectomy-driven acceleration of the metastatic process. Ann Oncol 16:1449-1457
24. Dunn GP, Old LJ, Schreiber RD (2004) The immunobiology of cancer immunosurveillance and immunoediting. Immunity 21:137-148
25. Elenkov IJ, Wilder RL, Chrousos GP, Vizi ES et al (2000) The sympathetic nerve - an integrative interface between two supersystems: the brain and the immune system. Pharmacol Rev 52:595-638
26. Exadaktylos AK, Buggy DJ, Moriarty DC et al (2006) Can anesthetic technique for primary breast cancer surgery affect recurrence or metastasis? Anesthesiology 105:660-664
27. Faist E, Ertel W, Cohnert T et al (1990) Immunoprotective effects of cyclooxygenase inhibition in patients with major surgical trauma. J Trauma 30:8-17
28. Faist E, Schinkel C, Zimmer S et al (1996) Update on the mechanisms of immune suppression of injury and immune modulation. World J Surg 20:454-459
29. Farooqui M, Li Y, Rogers T et al (2007) COX-2 inhibitor celecoxib prevents chronic morphine-induced promotion of angiogenesis, tumour growth, metastasis and mortality, without compromising analgesia. Br J Cancer 97:1523-1531
30. Fleischmann E, Marschalek C, Schlemitz K et al (2009) Nitrous oxide may not increase the risk of cancer recurrence after colorectal surgery: a follow-up of a randomized controlled trial. BMC Anesthesiol 9:1
31. Forget P, De Kock M (2009) Could anaesthesia, analgesia and sympathetic modulation affect neoplasic recurrence after surgery? A systematic review centred over the modulation of natural killer cells activity. Ann Fr Anesth Reanim 28:751-768
32. Forget P, Vendenhende J, Berliere M et al (2010) Do intraoperative analgesics influence breast cancer recurrence after mastectomy? A retrospective analysis. Anesth Analg 110:1630-1635
33. Forget P, Tombal B, Scholtes JL et al (2011) Do intraoperative analgesics influence oncological outcomes after radical prostatectomy for prostate cancer? Eur J Anaesthesiol 28:830-835
34. Fuggetta MP, Di Francesco P, Falchetti R et al (2005) Effect of morphine on cell-mediated immune responses of human lymphocytes against allogeneic malignant cells. J Exp Clin Cancer Res 24:255-263
35. Glasner A, Avraham R, Rosenne E et al (2011) Improving survival rates in two models of spontaneous postoperative metastasis in mice by combined administration of a beta-adrenergic antagonist and a cyclooxygenase-2 inhibitor. J Immunol 184:2449-2457
36. Goldfarb Y, Ben-Eliyahu S (2006) Surgery as a risk factor for breast cancer recurrence and metastasis: mediating mechanisms and clinical prophylactic approaches. Breast Dis 26:99-114
37. Gottschalk A, Ford JG, Reglin CC et al (2010a) Association between epidural analgesia and cancer recurrence after colorectal cancer surgery. Anesthesiology 113:27-34
38. Gottschalk A, Sharma S, Ford JG et al (2010b) Review article: the role of the perioperative period in recurrence after cancer surgery. Anesth Analg 110:1636-1643
39. Gupta K, Kshirsagar S, Chang L et al (2002) Morphine stimulates angiogenesis by activating proangiogenic and survival-promoting signaling and promotes breast tumor growth. Cancer Res 62:4491-4498
40. Gupta A, Bjornsson A, Fredriksson M et al (2011) Reduction in mortality after epidural anaesthesia and analgesia in patients undergoing rectal but not colonic cancer surgery: a retrospective analysis of data from 655 patients in central Sweden. Br J Anaesth 107:164-170
41. Hanahan D, Weinberg RA (2000) The hallmarks of cancer. Cell 100:57-70
42. Hengartner MO (2000) The biochemistry of apoptosis. Nature 407:770-776
43. Hollmann MW, Gross A, Jelacin A, Durieux ME (2001) Local anesthetic effects on priming and activation of human neutrophils. Anesthesiology 95:113-122
44. Hong JY, Lim KT (2008) Effect of preemptive epidural analgesia on cytokine response and postoperative pain in laparoscopic radical hysterectomy for cervical cancer. Reg Anesth Pain Med 33:44-51
45. Iglesias M, Segura MF, Comella JX, Olmos G (2003) Mu-opioid receptor activation prevents apoptosis following serum withdrawal in differentiated SH-SY5Y cells and cortical neurons via phosphatidylinositol 3-kinase. Neuropharmacology 44:482-492
46. Ismail H, Ho KM, Narayan K, Kondalsamy-Chennakesavan S (2010) Effect of neuraxial anaesthesia on tumour progression in cervical cancer patients treated with brachytherapy: a retrospective cohort study. Br J Anaesth 105:145-149
47. Keh D, Boehnke T, Weber-Cartens S et al (2003) Immunologic and hemodynamic effects of “low-dose” hydrocortisone in septic shock: a double-blind, randomized, placebo-controlled, crossover study. Am J Respir Crit Care Med 167:512-520
48. Kehlet H (1989) The stress response to surgery: release mechanisms and the modifying effect of pain relief. Acta Chir Scand Suppl 550:22-28
49. Kelly G, Strasser A (2011) The essential role of evasion from cell death in cancer. Adv Cancer Res 111:39-96
50. Koodie L, Ramakrishnan S, Roy S (2010) Morphine suppresses tumor angiogenesis through a HIF-1alpha/p38MAPK pathway. Am J Pathol 177:984-997
51. Kundu JK, Surh YJ (2008) Inflammation: gearing the journey to cancer. Mutat Res 659:15-30
52. Kurosawa S, Kato M (2008) Anesthetics, immune cells, and immune responses. J Anesth 22:263-277
53. Lai R, Peng Z, Chen D et al (2012) The effects of anesthetic technique on cancer recurrence in percutaneous radiofrequency ablation of small hepatocellular carcinoma. Anesth-Analg 114:290-296
54. Landen CN, Lin YG, Amaiz Pena GN et al (2007) Neuroendocrine modulation of signal transducer and activator of transcription-3 in ovarian cancer. Cancer Res 67:10389-10396
55. Leo S, Nuydens R, Meert TF (2009) Opioid-induced proliferation of vascular endothelial cells. J Pain Res 2:59-66
56. Lewis JW, Shavit Y, Terman GW et al (1983) Apparent involvement of opioid peptides in stress-induced enhancement of tumor growth. Peptides 4:635-638
57. Lin X, Wang YJ, Li Q et al (2009) Chronic high-dose morphine treatment promotes SH-SY5Y cell apoptosis via c-Jun N-terminal kinase-mediated activation of mitochondria-dependent pathway. FEBS J 276:2022-2036
58. Lin L, Liu C, Tan H et al (2011) Anaesthetic technique may affect the prognosis for ovarian serous adenocarcinoma: a retrospective analysis. Br J Anaesth 108:814-822
59. Lutgendorf SK, Cole S, Costanzo E et al (2003) Stress-related mediators stimulate vascular endothelial growth factor secretion by two ovarian cancer cell lines. Clin Cancer Res 9:4514-4521
60. MacGregor RR, Thorner RE, Wright DM (1980) Lidocaine inhibits granulocyte adherence and prevents granulocyte delivery to inflammatory sites. Blood 56:203-209
61. Magnusdottir H, Kirno K, Ricksten SE, Elam M (1999) High thoracic epidural anesthesia does not inhibit sympathetic nerve activity in the lower extremities. Anesthesiology 91:1299-1304
62. Marx J (2008) Cancer biology. All in the stroma: cancer’s Cosa Nostra. Science 320:38-41
63. Masur K, Niggemann B, Zanker KS, Entschladen F (2001) Norepinephrine-induced migration of SW 480 colon carcinoma cells is inhibited by beta-blockers. Cancer Res 61(7):2866-2869
64. McMillan DC, Wotherspoon HA, Fearon KC et al (1995) A prospective study of tumor recurrence and the acute-phase response after apparently curative colorectal cancer surgery. Am J Surg 170:319-322
65. Melamed R, Rosenne E, Shakhar K et al (2005) Marginating pulmonary-NK activity and resistance to experimental tumor metastasis: suppression by surgery and the prophylactic use of a beta-adrenergic antagonist and a prostaglandin synthesis inhibitor. Brain Behav Immun 19:114-126
66. Melchi CF, Mele A, Baliva G et al (1995) Prognostic value of anesthesia type for patients treated for cutaneous melanoma. Dermatol Surg 21:786-788
67. Mellon RD, Bayer BM (1998) Role of central opioid receptor subtypes in morphine-induced alterations in peripheral lymphocyte activity. Brain Res 789:56-67
68. Mikawa K, Akamarsu H, Nishina K et al (2003) Effects of ropivacaine on human neutrophil function: comparison with bupivacaine and lidocaine. Eur J Anaesthesiol 20:104-110
69. Moss J, Rosow CE (2008) Development of peripheral opioid antagonists’ new insights into opioid effects. Mayo Clin Proc 83:1116-1130
70. Myles PS, Peyton P, Silbert B et al (2011) Perioperative epidural analgesia for major abdominal surgery for cancer and recurrence-free survival: randomised trial. BMJ 342:d1491
71. Oliveira GS, Ahmad S, Schink J et al (2011) Intraoperative neuraxial anesthesia but not postoperative neuraxial analgesia is associated with increased relapse-free survival in ovarian cancer patients after primary cytoreductive surgery. Reg Anesth Pain Med 36:271-277
72. Page GG (2005) Surgery-induced immunosuppression and postoperative pain management. AACN Clin Issues 16:302-309 (quiz 416-418)
73. Pasi A, Qu BX, Steiner R (1991) Angiogenesis: modulation with opioids. Gen Pharmacol 22:1077-1079
74. Pera M, Nelson H, Rajkumar SV et al (2003) Influence of postoperative acute-phase response on angiogenesis and tumor growth: open vs. laparoscopic-assisted surgery in mice. J Gastrointest Surg 7:783-790
75. Raven R (1990) The theory and practice of oncology: historical evolution and present principles. Parthenon Publishing Group, Park Ridge
76. Reiche EMV, Nunes SO, Morimoto HK (2004) Stress, depression, the immune system, and cancer. Lancet Oncol 5:617-625
77. Rosenberg SA, Lotze MT, Yang JC et al (1993) Prospective randomized trial of high-dose interleukin-2 alone or in conjunction with lymphokine-activated killer cells for the treatment of patients with advanced cancer. J Natl Cancer Inst 85:622-632
78. Sacerdote P (2008) Opioid-induced immunosuppression. Curr Opin Support Palliat Care 2:14-18
79. Sacerdote P, Manfredi B, Bianchi M et al (1994) Intermitent but not continuous inescapable foot-shock stress affects immune response and immunocyte beta-endorphin concentration in the rats. Brain Behav Immun 8:251-260
80. Sacerdote P, Bianchi M, Gaspani L et al (2000) The effects of tramadol and morphine on immune responses and pain after surgery in cancer patients. Anesth Analg 90:1411-1414
81. Salo M (1996) Cytokines and attenuation of response to surgery. Acta Anaesthesiol Scan 40(2):141-142
82. Schlagenhauff B, Ellwanger U, Breuninger H, et al (2000) Prognostic impact of the type of anesthesia used during the excision of primary cutaneous melanoma. Melanoma Res 10(2): 165-169
83. Schmidt W, Schmidt H, Bauer H et al (1997) Influence of lidocaine on endotoxin-induced leukocyte-endothelial cell adhesion and macromolecular leakage in vivo. Anesthesiology 87(3):617-624
84. Seebacher C, Heubaum F, Kuster P et al (1990) Comparative analysis of narcosis and local anesthesia in surgery of malignant melanoma of skin. Hautarzt 41:137-141
85. Shavit Y, Martin FC, Yirmiya R et al (1987) Effects of single administration of morphine or footshock stress on natural killer cell cytotoxicity. Brain Behav Immun 1:318-328
86. Sinclair R, Eriksson AS, Gretzer C et al (1993) Inhibitory effects of amide local anaesthetics on stimulus-induced human leukocyte metabolic activation, LTB4 release and IL-1 secretion in vitro. Acta Anaesthesiol Scand 37:159-165
87. Snyder GL, Greenberg S (2010) Effect of anaesthetic technique and other perioperative factors on cancer recurrence. Br J Anaesth 105:106-115
88. Stein C, Rosow CE (2004) Analgesics: receptor ligands and opiate narcotics. In: Evers AS, Maze M (eds) Anesthetic pharmacology: physiologic principles and clinical practice. Churchill Livingstone, Philadelphia
89. Sueoka E, Sueoka N, Kai Y et al (1998) Anticancer activity of morphine and its synthetic derivative, KT-90, mediated through apoptosis and inhibition of NF-kappaB activation. Biochem Biophys Res Commun 252:566-570
90. Tegeder I, Grosch S, Schmidtko A et al (2003) G protein-independent G1 cell cycle block and apoptosis with morphine in adenocarcinoma cells: involvement of p53 phosphorylation. Cancer Res 63(8):1846-1852
91. Thaker PH, Han LY, Kamat AA et al (2006) Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma. Nat Med 12:939-944
92. Tsui BC, Rashiq S, Schoplfocher D et al (2010) Epidural anesthesia and cancer recurrence rates after radical prostatectomy. Can J Anaesth 57:107-112
93. Vallejo R, de Leon-Casasola O, Ramsun B (2004) Opioid therapy and immunosuppression: a review. Am J Ther 11:54-65
94. Wada H, Seki S, Takahashi T et al (2007) Combined spinal and general anesthesia attenuates liver metastasis by preserving TH1/TH2 cytokine balance. Anesthesiology 106:499-506
95. Welters I, Menzebach A, Goumon Y et al (2000) Morphine inhibits NF-kappaB nuclear binding in human neutrophils and monocytes by a nitric oxide-dependent mechanism. Anesthesiology 92:1677-1684
96. Wuethrich PY, Hsu Schmitz SF, Kessler TM et al (2011) Potential influence of the anesthetic technique used during open radical prostatectomy on prostate cancer-related outcome: a retrospective study. Anesthesiology 113:570-576
97. Yamashita JI, Kurusu Y, Fujino N et al (2000) Detection of circulating tumor cells in patients with non-small cell lung cancer undergoing lobectomy by video-assisted thoracic surgery: a potential hazard for intraoperative hematogenous tumor cell dissemination. J Thorac Cardiovasc Surg 119:899-905
98. Yanagi H, Sankawa H, Saito H, Likura Y (1996) Effect of lidocaine on histamine release and Ca2+ mobilization from mast cells and basophils. Acta Anaesthesiol Scand 40:1138-1144
99. Yang EV, Sood AK, Chen M et al (2006) Norepinephrine up-regulates the expression of vascular endothelial growth factor, matrix metalloproteinase (MMP)-2, and MMP-9 in nasopharyngeal carcinoma tumor cells. Cancer Res 66:10357-10364
100. Yardeni IZ, Beilin B, Mayburd E et al (2009) The effect of perioperative intravenous lidocaine on postoperative pain and immune function. Anesth Analg 109:1464-1469
101. Yeager MP, Colacchio TA, Yu CT et al (1995) Morphine inhibits spontaneous and cytokine-enhanced natural killer cell cytotoxicity in volunteers. Anesthesiology 83:500-508
102. Yeager MP, Procopio MA, DeLeo JA et al (2002) Intravenous fentanyl increases natural killer cell cytotoxicity and circulating CD16 (+) lymphocytes in humans. Anesth Analg 94:94-99
103. Yin D, Mufson RA, Wang R, Shi Y (1999) Fas-mediated cell death promoted by opioids. Nature 397:218
104. Yoshida AS, Tokuyama S, Iwamura T, Ueda H (2000) Opioid analgesic-induced apoptosis and caspase-independent cell death in human lung carcinoma A549 cells. Int J Mol Med 6:329-335